Clinton Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-41,268
Closed -$380K 1106
2016
Q4
$380K Buy
41,268
+5,660
+16% +$52.1K 0.02% 645
2016
Q3
$420K Buy
35,608
+18,240
+105% +$215K 0.02% 718
2016
Q2
$225K Buy
+17,368
New +$225K 0.01% 807